Zusammenfassung
Asthma bronchiale ist keine nosologische Einheit, sondern stellt ein durchaus heterogenes Krankheitsbild dar, bei dem erbliche Disposition und Umweltfaktoren in einer ambivalenten Wechselwirkung stehen und eine entscheidende Rolle für die Ausprägung der Erkrankung spielen. Idealerweise orientieren sich kausale Therapieansätze an den zugrunde liegenden Pathomechanismen. Da diese jedoch häufig schwer zu eruieren sind, besteht die Therapie des Asthma bronchiale auch heute noch im Wesentlichen aus symptomatischen Maßnahmen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Allen DB (2006) Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr 53: 101–110
Asher MI, Montefort S, Björksten B et al. and the ISAAC Phase Three Study Group (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368:733–743
Berdel D, Gappa M, Hamelmann E et al. (2010) Asthma bronchiale im Kindes- und Jugendalter. Leitlinien (LL) Kinder- und Jugendmedizin. Elsevier, Urban& Fischer, München. ISBN:978-3-437-22359-4
Brand BLP (2011) Inhaled corticosteroids should be the first line of treatment for children with asthma. Paediatric Respiratory Reviews 12: 245–249
Busse WW, Morgan WJ, Gergen PJ et al. (2011) Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children. N Engl J Med 364:1005–1015
Carroll CL, Bhandari A, Schramm CM, Zucker AR (2006) Chronic inhaled corticosteroids do not affect the course of acute severe asthma exacerbations in children. Pediatr Pulmonol 41: 1213–1217
Chipps BE, Szefler SJ, Simons FE et al. (2007) Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol 119: 1156–1163
De Blic J, Ogorodova L, Poterre M et al. (2009) Salmeterol/Fluticason propionate vs double dose fluticasone propionate on lung function and asthma control in children. Pediatr Allergy Immunol 20: 763–771
Eder W, Ege MJ, Mutius E von (2006) The asthma epidemic. N Engl J Med 355: 2226–2235
Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation. Nature 24 454: 445–454
Gappa M, Zachgo W, Berg von A et al. for the VIAPED Study Group. (2009) Add-on Salmeterol Compared to Double Dose Fluticasone in Pediatric Asthma A Double-Blind, Randomized Trial (VIAPED) Pediatric Pulmonology 44: 1132–1242
Garcia ML et al. (2005) Montelukast, compated with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: The MOSAIC study. Pediatrics 116: 360–369
GINA Report (2009) Global Strategy for Asthma Management and Prevention, update
Gould HJ, Sutton BJ (2008) IgE in allergy and asthma today. Nature Revs Immunol 8: 205–217
Holgate S, Casale T, Wenzel S et al. (2005) The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol 60: 305–316
ISAAC Steering Committee (1998) Worldwide variations in the prevalence of atopic diseases: the International Study of Asthma and Allergies in Childhood (ISAAC). Lancet 351: 1225–1232
Kew KM, Karner C, Mindus SM, Ferrara G (2013) Combination of formoterol ans budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev Dec 16 (Epub ahead of print)
Lemanske RF, Mauger DT, Taussig LM et al. (2010) Step up therapy for children with uncontrolled asthma receiving inhaled corticosteroids NEJM 362: 975–985
Martinez FD (2009) Managing childhood asthma: a challenge of preventing exazerbations Pediatrics 1213: 146–150
Martinez FD, Chinchilli VM, Morgan WJ et al. (2011) Use of beclomethason dipropionat as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 377: 650–657
McMahon AW, Levenson MS, McEvoy BW et al. (2011) Age and Risks of FDA–Approved Long-Acting β2-Adrenergic Receptor Agonists Pediatrics 128: 1147–1154
Milgrom H, Fowler-Taylor A, Vidaurre CF, Jayawardene S (2011) Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma. Curr Med Res Opin 27): 163–169
Moffatt MF, Gut IG, Demenais F et al.; GABRIEL Consortium (2010) A large-scale consortium-based genomewide association study of asthma. NEJM 363: 1211–1221
Moffatt MF, Kabesch M, Liang L et al. (2007) Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448: 470–473
Nationale VersorgungsLeitlinie (2011) Asthma, Langfassung, 2. Auflage, Version 1.3. AWMF Register: NVL-002, http://www.asthma.versorgungsleitlinie.de
Nikander K, Turpeinen M, Pelkonen AS et al. (2011) True adherence with the Turbuhaler in young children with asthma. Arch Dis Child 96:168–173
Papadopoulos NG, Arakawa H, Carlsen K-H et al. (2012) International consensus on (icon) pediatric asthma. Allergy 67: 976–997
Peroni D et al. (2005) Montelukast vs formoterol as second-line therapy in asthmatic children exposed to relevant allergens. Asthma Proc 26: 283–286
Peters SP, Kunselman SJ, Icitovic N et al. (2010) Tiotropium bromide step-up therapy for adults with uncontrolled asthma. NEJM 363: 1715–1726
Price D (2008) The use of omalizumab in asthma. Prim Care Resp J 17: 62–72
Price D, Musgrave SD, Shepstone L et al. (2011) Leukotriene antagonists as first-line or add-on asthma-controller therapy. NEJM 364: 1695–1707
Schultz A, Le Souëf TJ, Venter A et al. (2010) Aerosol inhalation from spacers and valved holding chambers requires few tidal breaths for children. Pediatrics 126: e1493–1498
Schwerk N, Brinkmann F, Soudah B, Kabesch M, Hansen G (2011) Wheeze in preschool age is associated with pulmonary bacterial infection and resolves after antibiotic therapy. Plos One PMID: 22140482
Szefler SJ, Carlsson LG, Uryniak T, Baker JW (2013) Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma. J All Clin Immunol Pract 1: 58-64
Weinmayr G, Weiland SK, Björksten B et al. (2007) Atopic sensitization and the international variation of asthma symptom prevalence in children Am J Respir Crit Care Med 176: 565–574
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Berdel, D., Reinhardt, D., Kabesch, M., Hansen, G. (2014). Asthma bronchiale. In: Reinhardt, D., Nicolai, T., Zimmer, KP. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41814-3_82
Download citation
DOI: https://doi.org/10.1007/978-3-642-41814-3_82
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41813-6
Online ISBN: 978-3-642-41814-3
eBook Packages: Medicine (German Language)